Relevant Therapeutic Approaches to Chronic Renal Failure

Chronic kidney disease (CKD) is an escalating global public health issue that can progress to end-stage renal failure, requiring dialysis or other renal replacement therapies. It is commonly associated with diabetes and hypertension, and disrupts vital bodily functions such as electrolyte balance, blood pressure regulation, vitamin D metabolism, and toxin excretion. As CKD advances, patients may develop serious complications including metabolic acidosis, hyperkalemia, hyperphosphatemia, diabetic nephropathy, and cardiovascular abnormalities. Key drivers of CKD progression include oxidative stress, chronic inflammation, intestinal stress, nephron loss, and accumulation of uremic toxins, all contributing to renal fibrosis and reduced regenerative capacity. Cardiovascular complications are a major concern in CKD management. Therapies like angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are effective in reducing proteinuria and slowing disease progression by 212 mitigating glomerular and tubulointerstitial damage. However, managing CKD remains complex and challenging. Emerging regenerative therapies and anti-inflammatory or antifibrotic agents hold promise in complementing existing treatments and reducing mortality. A comprehensive approach involving dietary regulation, pharmacological intervention, and personalized care strategies is crucial for preserving renal function. This chapter explores current knowledge, recent discoveries, and evolving therapeutic approaches to enhance CKD treatment outcomes.